Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$25.5 - $31.51 $2.43 Million - $3 Million
95,266 New
95,266 $2.73 Million
Q4 2022

Feb 14, 2023

BUY
$38.19 - $57.45 $503,076 - $756,788
13,173 New
13,173 $508,000
Q4 2021

Feb 10, 2022

SELL
$47.97 - $62.21 $356,752 - $462,655
-7,437 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$54.64 - $61.3 $167,089 - $187,455
-3,058 Reduced 29.14%
7,437 $416,000
Q2 2021

Aug 10, 2021

SELL
$59.18 - $69.99 $182,274 - $215,569
-3,080 Reduced 22.69%
10,495 $637,000
Q1 2021

Jul 21, 2021

BUY
$59.31 - $78.82 $166,661 - $221,484
2,810 Added 26.1%
13,575 $951,000
Q4 2020

Feb 12, 2021

SELL
$50.47 - $66.26 $334,717 - $439,436
-6,632 Reduced 38.12%
10,765 $644,000
Q3 2020

Oct 30, 2020

SELL
$51.97 - $63.0 $3.4 Million - $4.12 Million
-65,405 Reduced 78.99%
17,397 $1.05 Million
Q2 2020

Aug 05, 2020

SELL
$30.8 - $52.47 $1.88 Million - $3.2 Million
-61,022 Reduced 42.43%
82,802 $4.35 Million
Q1 2020

May 11, 2020

SELL
$28.4 - $50.7 $505,804 - $902,967
-17,810 Reduced 11.02%
143,824 $4.82 Million
Q4 2019

Feb 13, 2020

BUY
$36.31 - $46.83 $4.25 Million - $5.48 Million
117,039 Added 262.45%
161,634 $7.32 Million
Q3 2019

Nov 08, 2019

BUY
$35.66 - $44.99 $1.59 Million - $2.01 Million
44,595 New
44,595 $1.7 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.19B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.